Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Pancreatic cancer is particularly refractory to therapy, with a current dismal five-year survival rate for patients of about 8%. One of the significant barriers to effective treatment is the immunosuppressive pancreatic tumor microenvironment and development of resistance to treatment. New treatment options to increase survival and quality of life of patients are urgently needed. This study reports on a new non-cannabinoid, non-psychoactive derivative of cannabis, called FBL-03G, with the potential to treat pancreatic cancer. In-vitro results show major increase in apoptosis and consequential decrease in survival for different pancreatic cancer models: Panc-02 and KPC pancreatic cancer cells treated with varying concentrations of FBL-03G and radiotherapy. Meanwhile, in-vivo results demonstrate therapeutic efficacy in delaying both local and metastatic tumor progression in animal models with pancreatic cancer when using FBL-03G sustainably delivered from smart radiotherapy biomaterials. Repeated experiments also showed significant (P < 0.001) increase in survival for animals with pancreatic cancer compared to control cohorts. The findings demonstrate potential for this new cannabis derivative in treatment of both localized and advanced pancreatic cancer, providing impetus for further studies towards clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570 · cited 1×
“A major challenge shared by pancreatic cancers is its aggressiveness, which often metastasizes to other organs before the patient is even diagnosed (3, 4).”
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348 · cited 5×
“Pancreatic ductal adenocarcinoma is an antagonistic internecine ailment of the exocrine pancreas with < 8% of patients surviving within a 5-year period (1, 2).”
InfluentialCannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Cannabis sativa: The Plant of the Thousand and One Molecules
Andre, C. M., Hausman, J.-F., & Guerriero, G. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00019 · Cited by 1,544
Using immunotherapy to boost the abscopal effect
Ngwa, W., Irabor, O. C., Schoenfeld, J. D., Hesser, J., Demaria, S., & Formenti, S. C. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.6 · Cited by 1,260
Self-citationBiologically Active Cannabinoids from High-Potency Cannabis sativa
Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Khan, I. A., & Ross, S. A. (2009) · Journal of Natural Products · doi:10.1021/np900067k · Cited by 185 · cited 1×
“Through a bioactivity guided isolation approach, 11 flavonoids were isolated using flash chromatography and characterized by nuclear magnetic resonance (NMR) andmass spectrometry (MS) methods (2, 16, 17).”
Isolation from cannabis sativa L. of cannflavin—a novel inhibitor of prostaglandin production
Barrett, M. L., Gordon, D., & Evans, F. J. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90325-9 · Cited by 83
Cited by
Flavonoids in Cannabis sativa: Biosynthesis, Bioactivities, and Biotechnology
Bautista, J. L., Yu, S., & Tian, L. (2021) · ACS Omega · doi:10.1021/acsomega.1c00318 · Cited by 144
Cannflavins—From plant to patient: A scoping review
Erridge, S., Mangal, N., Salazar, O., Pacchetti, B., & Sodergren, M. H. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104712 · Cited by 45
Chemistry and Biological Activities of Cannflavins of the Cannabis Plant
Abdel-Kader, M. S., Radwan, M. M., Metwaly, A. M., Eissa, I. H., Hazekamp, A., & ElSohly, M. A. (2023) · Cannabis & Cannabinoid Research · doi:10.1089/can.2023.0128 · Cited by 28
“28 Furthermore, Brunelli et al. reported the potential of isocannflavin B in autophagy, and the removal and regulation of dysfunctional intracellular compositions, in estrogen-sensitive and -insensitive breast cancer cell lines.”
Background
Metadata
- Authors
- Moreau, M., Ibeh, U., Decosmo, K., Bih, N., Yasmin-Karim, S., Toyang, N., Lowe, H., & Ngwa, W.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-07-23
- Volume
- 9
- Pages
- 1434-1434
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2955274009
- Cited by
- 43
- References
- 7
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer. https://app.cochat.ai/papers/10.3389/fonc.2019.00660
- The paper
- Moreau, M., Ibeh, U., Decosmo, K., Bih, N., Yasmin-Karim, S., Toyang, N., Lowe, H., & Ngwa, W. (2019). Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer. Frontiers in Oncology. https://doi.org/10.3389/fonc.2019.00660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.